Alisa Lee Sherick MD
University of Colorado Denver
Targeting MerTK as an immunotherapeutic strategy in pediatric acute myeloid leukemia
Delfim Duarte, MD PhD
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
Alexandra Stevens, MD, PhD
Baylor College of Medicine
Predicting Atovaquone-Induced Apoptosis in Pediatric AML
Grant Rowe, MD PhD
Children’s Hospital Boston
Targeting leukemia stem cells in infant B-lymphoblastic leukemia
This grant is funded by Change a Life Foundation
Christopher Ott, Ph.D.
Massachusetts General Hospital
Discovery of Epigenetic Factors Essential for T Cell Leukemia
Jessica L. Heath, MD
University of Vermont
Critical Contributions of CRM1 to Pediatric Leukemogenesis.
John Carter, MD, PhD
Fred Hutchinson Cancer Research Center at Seattle Children's Hospital
Identification of novel cdk4/6 effectors in T cell acute lymphoblastic leukemia
Kira Bona, MD, MPH
Dana-Farber Cancer Institute, Harvard
Development of a Material Hardship Intervention
Gregory J. Aune, MD, PhD
UT Health Science Center San Antonio
Pre-clinical Evaluation of Anthracycline Equivalency
Awarded in partnership with Insomniac Cares